News | April 12, 2022
Wacker, CordenPharma to produce mRNA vaccines for Germany
Both companies have been selected for stand-by production by German government
Both companies have been selected for stand-by production by German government
Veeda Clinical Research will submit data in an application for Emergency Use Authorisation
Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
Sputnik Light is the first component of Sputnik V
Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
Govt announces vaccination programme for kids and those above 60 years of age
Subscribe To Our Newsletter & Stay Updated
